US FTC head makes economic case against "reverse payment" deals
This article was originally published in Scrip
Executive Summary
Eliminating "reverse payment" patent settlements between innovators and generics firms would save US consumers about $3.5 billion a year, one third of which would accrue to the federal government, US Federal Trade Commission (FTC) chairman Jon Leibowitz said in a speech to the Center for American Progress.